1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global AI Drug Development Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Drug Design 1.2.3 Drug Synthesis 1.2.4 Other 1.3 Market by Application 1.3.1 Global AI Drug Development Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Tumor 1.3.3 Nervous System 1.3.4 Other 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global AI Drug Development Market Perspective (2016-2027) 2.2 AI Drug Development Growth Trends by Regions 2.2.1 AI Drug Development Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 AI Drug Development Historic Market Share by Regions (2016-2021) 2.2.3 AI Drug Development Forecasted Market Size by Regions (2022-2027) 2.3 AI Drug Development Industry Dynamic 2.3.1 AI Drug Development Market Trends 2.3.2 AI Drug Development Market Drivers 2.3.3 AI Drug Development Market Challenges 2.3.4 AI Drug Development Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top AI Drug Development Players by Revenue 3.1.1 Global Top AI Drug Development Players by Revenue (2016-2021) 3.1.2 Global AI Drug Development Revenue Market Share by Players (2016-2021) 3.2 Global AI Drug Development Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by AI Drug Development Revenue 3.4 Global AI Drug Development Market Concentration Ratio 3.4.1 Global AI Drug Development Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by AI Drug Development Revenue in 2020 3.5 AI Drug Development Key Players Head office and Area Served 3.6 Key Players AI Drug Development Product Solution and Service 3.7 Date of Enter into AI Drug Development Market 3.8 Mergers & Acquisitions, Expansion Plans 4 AI Drug Development Breakdown Data by Type 4.1 Global AI Drug Development Historic Market Size by Type (2016-2021) 4.2 Global AI Drug Development Forecasted Market Size by Type (2022-2027) 5 AI Drug Development Breakdown Data by Application 5.1 Global AI Drug Development Historic Market Size by Application (2016-2021) 5.2 Global AI Drug Development Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America AI Drug Development Market Size (2016-2027) 6.2 North America AI Drug Development Market Size by Type 6.2.1 North America AI Drug Development Market Size by Type (2016-2021) 6.2.2 North America AI Drug Development Market Size by Type (2022-2027) 6.2.3 North America AI Drug Development Market Size by Type (2016-2027) 6.3 North America AI Drug Development Market Size by Application 6.3.1 North America AI Drug Development Market Size by Application (2016-2021) 6.3.2 North America AI Drug Development Market Size by Application (2022-2027) 6.3.3 North America AI Drug Development Market Size by Application (2016-2027) 6.4 North America AI Drug Development Market Size by Country 6.4.1 North America AI Drug Development Market Size by Country (2016-2021) 6.4.2 North America AI Drug Development Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe AI Drug Development Market Size (2016-2027) 7.2 Europe AI Drug Development Market Size by Type 7.2.1 Europe AI Drug Development Market Size by Type (2016-2021) 7.2.2 Europe AI Drug Development Market Size by Type (2022-2027) 7.2.3 Europe AI Drug Development Market Size by Type (2016-2027) 7.3 Europe AI Drug Development Market Size by Application 7.3.1 Europe AI Drug Development Market Size by Application (2016-2021) 7.3.2 Europe AI Drug Development Market Size by Application (2022-2027) 7.3.3 Europe AI Drug Development Market Size by Application (2016-2027) 7.4 Europe AI Drug Development Market Size by Country 7.4.1 Europe AI Drug Development Market Size by Country (2016-2021) 7.4.2 Europe AI Drug Development Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific AI Drug Development Market Size (2016-2027) 8.2 Asia-Pacific AI Drug Development Market Size by Type 8.2.1 Asia-Pacific AI Drug Development Market Size by Type (2016-2021) 8.2.2 Asia-Pacific AI Drug Development Market Size by Type (2022-2027) 8.2.3 Asia-Pacific AI Drug Development Market Size by Type (2016-2027) 8.3 Asia-Pacific AI Drug Development Market Size by Application 8.3.1 Asia-Pacific AI Drug Development Market Size by Application (2016-2021) 8.3.2 Asia-Pacific AI Drug Development Market Size by Application (2022-2027) 8.3.3 Asia-Pacific AI Drug Development Market Size by Application (2016-2027) 8.4 Asia-Pacific AI Drug Development Market Size by Region 8.4.1 Asia-Pacific AI Drug Development Market Size by Region (2016-2021) 8.4.2 Asia-Pacific AI Drug Development Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America AI Drug Development Market Size (2016-2027) 9.2 Latin America AI Drug Development Market Size by Type 9.2.1 Latin America AI Drug Development Market Size by Type (2016-2021) 9.2.2 Latin America AI Drug Development Market Size by Type (2022-2027) 9.2.3 Latin America AI Drug Development Market Size by Type (2016-2027) 9.3 Latin America AI Drug Development Market Size by Application 9.3.1 Latin America AI Drug Development Market Size by Application (2016-2021) 9.3.2 Latin America AI Drug Development Market Size by Application (2022-2027) 9.3.3 Latin America AI Drug Development Market Size by Application (2016-2027) 9.4 Latin America AI Drug Development Market Size by Country 9.4.1 Latin America AI Drug Development Market Size by Country (2016-2021) 9.4.2 Latin America AI Drug Development Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa AI Drug Development Market Size (2016-2027) 10.2 Middle East & Africa AI Drug Development Market Size by Type 10.2.1 Middle East & Africa AI Drug Development Market Size by Type (2016-2021) 10.2.2 Middle East & Africa AI Drug Development Market Size by Type (2022-2027) 10.2.3 Middle East & Africa AI Drug Development Market Size by Type (2016-2027) 10.3 Middle East & Africa AI Drug Development Market Size by Application 10.3.1 Middle East & Africa AI Drug Development Market Size by Application (2016-2021) 10.3.2 Middle East & Africa AI Drug Development Market Size by Application (2022-2027) 10.3.3 Middle East & Africa AI Drug Development Market Size by Application (2016-2027) 10.4 Middle East & Africa AI Drug Development Market Size by Country 10.4.1 Middle East & Africa AI Drug Development Market Size by Country (2016-2021) 10.4.2 Middle East & Africa AI Drug Development Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Insilico Medicine 11.1.1 Insilico Medicine Company Details 11.1.2 Insilico Medicine Business Overview 11.1.3 Insilico Medicine AI Drug Development Introduction 11.1.4 Insilico Medicine Revenue in AI Drug Development Business (2016-2021) 11.1.5 Insilico Medicine Recent Development 11.2 Cyclica 11.2.1 Cyclica Company Details 11.2.2 Cyclica Business Overview 11.2.3 Cyclica AI Drug Development Introduction 11.2.4 Cyclica Revenue in AI Drug Development Business (2016-2021) 11.2.5 Cyclica Recent Development 11.3 XtalPi Inc. 11.3.1 XtalPi Inc. Company Details 11.3.2 XtalPi Inc. Business Overview 11.3.3 XtalPi Inc. AI Drug Development Introduction 11.3.4 XtalPi Inc. Revenue in AI Drug Development Business (2016-2021) 11.3.5 XtalPi Inc. Recent Development 11.4 Exscientia Limited 11.4.1 Exscientia Limited Company Details 11.4.2 Exscientia Limited Business Overview 11.4.3 Exscientia Limited AI Drug Development Introduction 11.4.4 Exscientia Limited Revenue in AI Drug Development Business (2016-2021) 11.4.5 Exscientia Limited Recent Development 11.5 AiCure, LLC 11.5.1 AiCure, LLC Company Details 11.5.2 AiCure, LLC Business Overview 11.5.3 AiCure, LLC AI Drug Development Introduction 11.5.4 AiCure, LLC Revenue in AI Drug Development Business (2016-2021) 11.5.5 AiCure, LLC Recent Development 11.6 Atomwise 11.6.1 Atomwise Company Details 11.6.2 Atomwise Business Overview 11.6.3 Atomwise AI Drug Development Introduction 11.6.4 Atomwise Revenue in AI Drug Development Business (2016-2021) 11.6.5 Atomwise Recent Development 11.7 Biovista Inc. 11.7.1 Biovista Inc. Company Details 11.7.2 Biovista Inc. Business Overview 11.7.3 Biovista Inc. AI Drug Development Introduction 11.7.4 Biovista Inc. Revenue in AI Drug Development Business (2016-2021) 11.7.5 Biovista Inc. Recent Development 11.8 Breg，Inc. 11.8.1 Breg，Inc. Company Details 11.8.2 Breg，Inc. Business Overview 11.8.3 Breg，Inc. AI Drug Development Introduction 11.8.4 Breg，Inc. Revenue in AI Drug Development Business (2016-2021) 11.8.5 Breg，Inc. Recent Development 11.9 Numerate 11.9.1 Numerate Company Details 11.9.2 Numerate Business Overview 11.9.3 Numerate AI Drug Development Introduction 11.9.4 Numerate Revenue in AI Drug Development Business (2016-2021) 11.9.5 Numerate Recent Development 11.10 Cloud Pharmaceuticals 11.10.1 Cloud Pharmaceuticals Company Details 11.10.2 Cloud Pharmaceuticals Business Overview 11.10.3 Cloud Pharmaceuticals AI Drug Development Introduction 11.10.4 Cloud Pharmaceuticals Revenue in AI Drug Development Business (2016-2021) 11.10.5 Cloud Pharmaceuticals Recent Development 11.11 IBM 11.11.1 IBM Company Details 11.11.2 IBM Business Overview 11.11.3 IBM AI Drug Development Introduction 11.11.4 IBM Revenue in AI Drug Development Business (2016-2021) 11.11.5 IBM Recent Development 11.12 NuMedii 11.12.1 NuMedii Company Details 11.12.2 NuMedii Business Overview 11.12.3 NuMedii AI Drug Development Introduction 11.12.4 NuMedii Revenue in AI Drug Development Business (2016-2021) 11.12.5 NuMedii Recent Development 11.13 BenevolentAI 11.13.1 BenevolentAI Company Details 11.13.2 BenevolentAI Business Overview 11.13.3 BenevolentAI AI Drug Development Introduction 11.13.4 BenevolentAI Revenue in AI Drug Development Business (2016-2021) 11.13.5 BenevolentAI Recent Development 11.14 Lam Therapeutics 11.14.1 Lam Therapeutics Company Details 11.14.2 Lam Therapeutics Business Overview 11.14.3 Lam Therapeutics AI Drug Development Introduction 11.14.4 Lam Therapeutics Revenue in AI Drug Development Business (2016-2021) 11.14.5 Lam Therapeutics Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global AI Drug Development Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Drug Design Table 3. Key Players of Drug Synthesis Table 4. Key Players of Other Table 5. Global AI Drug Development Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global AI Drug Development Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global AI Drug Development Market Size by Regions (2016-2021) & (US$ Million) Table 8. Global AI Drug Development Market Share by Regions (2016-2021) Table 9. Global AI Drug Development Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 10. Global AI Drug Development Market Share by Regions (2022-2027) Table 11. AI Drug Development Market Trends Table 12. AI Drug Development Market Drivers Table 13. AI Drug Development Market Challenges Table 14. AI Drug Development Market Restraints Table 15. Global AI Drug Development Revenue by Players (2016-2021) & (US$ Million) Table 16. Global AI Drug Development Market Share by Players (2016-2021) Table 17. Global Top AI Drug Development Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in AI Drug Development as of 2020) Table 18. Ranking of Global Top AI Drug Development Companies by Revenue (US$ Million) in 2020 Table 19. Global 5 Largest Players Market Share by AI Drug Development Revenue (CR5 and HHI) & (2016-2021) Table 20. Key Players Headquarters and Area Served Table 21. Key Players AI Drug Development Product Solution and Service Table 22. Date of Enter into AI Drug Development Market Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global AI Drug Development Market Size by Type (2016-2021) (US$ Million) Table 25. Global AI Drug Development Revenue Market Share by Type (2016-2021) Table 26. Global AI Drug Development Forecasted Market Size by Type (2022-2027) (US$ Million) Table 27. Global AI Drug Development Revenue Market Share by Type (2022-2027) & (US$ Million) Table 28. Global AI Drug Development Market Size Share by Application (2016-2021) & (US$ Million) Table 29. Global AI Drug Development Revenue Market Share by Application (2016-2021) Table 30. Global AI Drug Development Forecasted Market Size by Application (2022-2027) (US$ Million) Table 31. Global AI Drug Development Revenue Market Share by Application (2022-2027) & (US$ Million) Table 32. North America AI Drug Development Market Size by Type (2016-2021) (US$ Million) Table 33. North America AI Drug Development Market Size by Type (2022-2027) & (US$ Million) Table 34. North America AI Drug Development Market Size by Application (2016-2021) (US$ Million) Table 35. North America AI Drug Development Market Size by Application (2022-2027) & (US$ Million) Table 36. North America AI Drug Development Market Size by Country (2016-2021) & (US$ Million) Table 37. North America AI Drug Development Market Size by Country (2022-2027) & (US$ Million) Table 38. Europe AI Drug Development Market Size by Type (2016-2021) (US$ Million) Table 39. Europe AI Drug Development Market Size by Type (2022-2027) & (US$ Million) Table 40. Europe AI Drug Development Market Size by Application (2016-2021) (US$ Million) Table 41. Europe AI Drug Development Market Size by Application (2022-2027) & (US$ Million) Table 42. Europe AI Drug Development Market Size by Country (2016-2021) & (US$ Million) Table 43. Europe AI Drug Development Market Size by Country (2022-2027) & (US$ Million) Table 44. Asia-Pacific AI Drug Development Market Size by Type (2016-2021) (US$ Million) Table 45. Asia-Pacific AI Drug Development Market Size by Type (2022-2027) & (US$ Million) Table 46. Asia-Pacific AI Drug Development Market Size by Application (2016-2021) (US$ Million) Table 47. Asia-Pacific AI Drug Development Market Size by Application (2022-2027) & (US$ Million) Table 48. Asia-Pacific AI Drug Development Market Size by Region (2016-2021) & (US$ Million) Table 49. Asia-Pacific AI Drug Development Market Size by Region (2022-2027) & (US$ Million) Table 50. Latin America AI Drug Development Market Size by Type (2016-2021) (US$ Million) Table 51. Latin America AI Drug Development Market Size by Type (2022-2027) & (US$ Million) Table 52. Latin America AI Drug Development Market Size by Application (2016-2021) (US$ Million) Table 53. Latin America AI Drug Development Market Size by Application (2022-2027) & (US$ Million) Table 54. Latin America AI Drug Development Market Size by Country (2016-2021) & (US$ Million) Table 55. Latin America AI Drug Development Market Size by Country (2022-2027) & (US$ Million) Table 56. Middle East & Africa AI Drug Development Market Size by Type (2016-2021) (US$ Million) Table 57. Middle East & Africa AI Drug Development Market Size by Type (2022-2027) & (US$ Million) Table 58. Middle East & Africa AI Drug Development Market Size by Application (2016-2021) (US$ Million) Table 59. Middle East & Africa AI Drug Development Market Size by Application (2022-2027) & (US$ Million) Table 60. Middle East & Africa AI Drug Development Market Size by Country (2016-2021) & (US$ Million) Table 61. Middle East & Africa AI Drug Development Market Size by Country (2022-2027) & (US$ Million) Table 62. Insilico Medicine Company Details Table 63. Insilico Medicine Business Overview Table 64. Insilico Medicine AI Drug Development Product Table 65. Insilico Medicine Revenue in AI Drug Development Business (2016-2021) & (US$ Million) Table 66. Insilico Medicine Recent Development Table 67. Cyclica Company Details Table 68. Cyclica Business Overview Table 69. Cyclica AI Drug Development Product Table 70. Cyclica Revenue in AI Drug Development Business (2016-2021) & (US$ Million) Table 71. Cyclica Recent Development Table 72. XtalPi Inc. Company Details Table 73. XtalPi Inc. Business Overview Table 74. XtalPi Inc. AI Drug Development Product Table 75. XtalPi Inc. Revenue in AI Drug Development Business (2016-2021) & (US$ Million) Table 76. XtalPi Inc. Recent Development Table 77. Exscientia Limited Company Details Table 78. Exscientia Limited Business Overview Table 79. Exscientia Limited AI Drug Development Product Table 80. Exscientia Limited Revenue in AI Drug Development Business (2016-2021) & (US$ Million) Table 81. Exscientia Limited Recent Development Table 82. AiCure, LLC Company Details Table 83. AiCure, LLC Business Overview Table 84. AiCure, LLC AI Drug Development Product Table 85. AiCure, LLC Revenue in AI Drug Development Business (2016-2021) & (US$ Million) Table 86. AiCure, LLC Recent Development Table 87. Atomwise Company Details Table 88. Atomwise Business Overview Table 89. Atomwise AI Drug Development Product Table 90. Atomwise Revenue in AI Drug Development Business (2016-2021) & (US$ Million) Table 91. Atomwise Recent Development Table 92. Biovista Inc. Company Details Table 93. Biovista Inc. Business Overview Table 94. Biovista Inc. AI Drug Development Product Table 95. Biovista Inc. Revenue in AI Drug Development Business (2016-2021) & (US$ Million) Table 96. Biovista Inc. Recent Development Table 97. Breg，Inc. Company Details Table 98. Breg，Inc. Business Overview Table 99. Breg，Inc. Revenue in AI Drug Development Business (2016-2021) & (US$ Million) Table 100. Breg，Inc. Recent Development Table 101. Numerate Company Details Table 102. Numerate Business Overview Table 103. Numerate AI Drug Development Product Table 104. Numerate Revenue in AI Drug Development Business (2016-2021) & (US$ Million) Table 105. Numerate Recent Development Table 106. Cloud Pharmaceuticals Company Details Table 107. Cloud Pharmaceuticals Business Overview Table 108. Cloud Pharmaceuticals AI Drug Development Product Table 109. Cloud Pharmaceuticals Revenue in AI Drug Development Business (2016-2021) & (US$ Million) Table 110. Cloud Pharmaceuticals Recent Development Table 111. IBM Company Details Table 112. IBM Business Overview Table 113. IBM AI Drug Development Product Table 114. IBM Revenue in AI Drug Development Business (2016-2021) & (US$ Million) Table 115. IBM Recent Development Table 116. NuMedii Company Details Table 117. NuMedii Business Overview Table 118. NuMedii AI Drug Development Product Table 119. NuMedii Revenue in AI Drug Development Business (2016-2021) & (US$ Million) Table 120. NuMedii Recent Development Table 121. BenevolentAI Company Details Table 122. BenevolentAI Business Overview Table 123. BenevolentAI AI Drug Development Product Table 124. BenevolentAI Revenue in AI Drug Development Business (2016-2021) & (US$ Million) Table 125. BenevolentAI Recent Development Table 126. Lam Therapeutics Company Details Table 127. Lam Therapeutics Business Overview Table 128. Lam Therapeutics AI Drug Development Product Table 129. Lam Therapeutics Revenue in AI Drug Development Business (2016-2021) & (US$ Million) Table 130. Lam Therapeutics Recent Development Table 131. Research Programs/Design for This Report Table 132. Key Data Information from Secondary Sources Table 133. Key Data Information from Primary Sources List of Figures Figure 1. Global AI Drug Development Market Share by Type: 2020 VS 2027 Figure 2. Drug Design Features Figure 3. Drug Synthesis Features Figure 4. Other Features Figure 5. Global AI Drug Development Market Share by Application: 2020 VS 2027 Figure 6. Tumor Case Studies Figure 7. Nervous System Case Studies Figure 8. Other Case Studies Figure 9. AI Drug Development Report Years Considered Figure 10. Global AI Drug Development Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 11. Global AI Drug Development Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 12. Global AI Drug Development Market Share by Regions: 2020 VS 2027 Figure 13. Global AI Drug Development Market Share by Regions (2022-2027) Figure 14. Global AI Drug Development Market Share by Players in 2020 Figure 15. Global Top AI Drug Development Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in AI Drug Development as of 2020 Figure 16. The Top 10 and 5 Players Market Share by AI Drug Development Revenue in 2020 Figure 17. Global AI Drug Development Revenue Market Share by Type (2016-2021) Figure 18. Global AI Drug Development Revenue Market Share by Type (2022-2027) Figure 19. North America AI Drug Development Market Size YoY Growth (2016-2027) & (US$ Million) Figure 20. North America AI Drug Development Market Share by Type (2016-2027) Figure 21. North America AI Drug Development Market Share by Application (2016-2027) Figure 22. North America AI Drug Development Market Share by Country (2016-2027) Figure 23. United States AI Drug Development Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Canada AI Drug Development Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Europe AI Drug Development Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Europe AI Drug Development Market Share by Type (2016-2027) Figure 27. Europe AI Drug Development Market Share by Application (2016-2027) Figure 28. Europe AI Drug Development Market Share by Country (2016-2027) Figure 29. Germany AI Drug Development Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. France AI Drug Development Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. U.K. AI Drug Development Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Italy AI Drug Development Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Russia AI Drug Development Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Nordic AI Drug Development Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Asia-Pacific AI Drug Development Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Asia-Pacific AI Drug Development Market Share by Type (2016-2027) Figure 37. Asia-Pacific AI Drug Development Market Share by Application (2016-2027) Figure 38. Asia-Pacific AI Drug Development Market Share by Region (2016-2027) Figure 39. China AI Drug Development Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. Japan AI Drug Development Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. South Korea AI Drug Development Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. Southeast Asia AI Drug Development Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. India AI Drug Development Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Australia AI Drug Development Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Latin America AI Drug Development Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Latin America AI Drug Development Market Share by Type (2016-2027) Figure 47. Latin America AI Drug Development Market Share by Application (2016-2027) Figure 48. Latin America AI Drug Development Market Share by Country (2016-2027) Figure 49. Mexico AI Drug Development Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Brazil AI Drug Development Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Middle East & Africa AI Drug Development Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Middle East & Africa AI Drug Development Market Share by Type (2016-2027) Figure 53. Middle East & Africa AI Drug Development Market Share by Application (2016-2027) Figure 54. Middle East & Africa AI Drug Development Market Share by Country (2016-2027) Figure 55. Turkey AI Drug Development Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. Saudi Arabia AI Drug Development Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. UAE AI Drug Development Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. Insilico Medicine Revenue Growth Rate in AI Drug Development Business (2016-2021) Figure 59. Cyclica Revenue Growth Rate in AI Drug Development Business (2016-2021) Figure 60. XtalPi Inc. Revenue Growth Rate in AI Drug Development Business (2016-2021) Figure 61. Exscientia Limited Revenue Growth Rate in AI Drug Development Business (2016-2021) Figure 62. AiCure, LLC Revenue Growth Rate in AI Drug Development Business (2016-2021) Figure 63. Atomwise Revenue Growth Rate in AI Drug Development Business (2016-2021) Figure 64. Biovista Inc. Revenue Growth Rate in AI Drug Development Business (2016-2021) Figure 65. Breg，Inc. Revenue Growth Rate in AI Drug Development Business (2016-2021) Figure 66. Numerate Revenue Growth Rate in AI Drug Development Business (2016-2021) Figure 67. Cloud Pharmaceuticals Revenue Growth Rate in AI Drug Development Business (2016-2021) Figure 68. IBM Revenue Growth Rate in AI Drug Development Business (2016-2021) Figure 69. NuMedii Revenue Growth Rate in AI Drug Development Business (2016-2021) Figure 70. BenevolentAI Revenue Growth Rate in AI Drug Development Business (2016-2021) Figure 71. Lam Therapeutics Revenue Growth Rate in AI Drug Development Business (2016-2021) Figure 72. Bottom-up and Top-down Approaches for This Report Figure 73. Data Triangulation Figure 74. Key Executives Interviewed

Insilico Medicine Cyclica XtalPi Inc. Exscientia Limited AiCure, LLC Atomwise Biovista Inc. Breg，Inc. Numerate Cloud Pharmaceuticals IBM NuMedii BenevolentAI Lam Therapeutics